Neil Desai
Presidente en AADI BIOSCIENCE, INC. .
Fortuna: 3 M $ al 30/04/2024
Cargos activos de Neil Desai
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AADI BIOSCIENCE, INC. | Presidente | 01/01/2023 | - |
Director/Miembro de la Junta | 01/10/2011 | 01/01/2023 | |
Director Ejecutivo | 01/10/2011 | 01/01/2023 | |
Presidente | 01/10/2011 | 01/01/2023 | |
Secretario Corporativo | 01/10/2011 | 01/01/2023 | |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Fundador | 01/10/2011 | - |
Director/Miembro de la Junta | 01/10/2011 | 01/01/2023 | |
Director Ejecutivo | 01/10/2011 | 01/01/2023 | |
Presidente | 01/10/2011 | 01/01/2023 | |
Secretario Corporativo | 01/10/2011 | 01/01/2023 |
Historial de carrera de Neil Desai
Antiguos cargos conocidos de Neil Desai.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CELGENE | Corporate Officer/Principal | 01/10/2010 | 01/10/2016 |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Director Técnico/Científico/I+D | 01/11/2008 | 01/10/2010 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Director Técnico/Científico/I+D | 01/03/1999 | 01/10/2008 |
Mercator MedSystems, Inc.
Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Mercator MedSystems, Inc. develops medical injection devices. The firm focuses on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. It offers bullfrog micro-infusion device and blowfish trans-bronchial micro-infusion device. The company was founded by Kirk Patrick Seward, Michael Vestel, and Albert P. Pisano in 2000 and is headquartered in Emeryville, CA. | Director/Miembro de la Junta | 15/02/2011 | - |
American Bioscience, Inc. | Director Técnico/Científico/I+D | 01/01/1991 | - |
Formación de Neil Desai.
The University of Texas at Austin | Doctorate Degree |
Institute of Chemical Technology | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
India | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Sectorial
Health Technology | 8 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
AADI BIOSCIENCE, INC. | Health Technology |
Empresas privadas | 6 |
---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
American Bioscience, Inc. | Health Technology |
Mercator MedSystems, Inc.
Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Mercator MedSystems, Inc. develops medical injection devices. The firm focuses on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. It offers bullfrog micro-infusion device and blowfish trans-bronchial micro-infusion device. The company was founded by Kirk Patrick Seward, Michael Vestel, and Albert P. Pisano in 2000 and is headquartered in Emeryville, CA. | Health Technology |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Neil Desai
- Experiencia